• Mitomycin C in Translational Oncology: Mechanism, Models, an

  2026-06-19

  This thought-leadership article explores the mechanistic and strategic landscape of Mitomycin C as a gold-standard antitumor antibiotic. Bridging fresh mechanistic insights from DNA replication inhibition and apoptosis signaling to actionable guidance for translational researchers, the piece contextualizes Mitomycin C’s evolving role, citing recent discoveries in centromeric transcription and competitive research protocols. Aimed at empowering cancer biology teams, it delivers nuanced recommendations, protocol parameters, and a visionary outlook for future model integration.

• Palonosetron Hydrochloride in CINV Prevention: Mechanisms an

  2026-06-19

  Ruhlmann and Herrstedt's review highlights palonosetron hydrochloride as a next-generation 5-HT3 receptor antagonist with unique pharmacological properties and extended antiemetic efficacy, distinguishing it from earlier agents for chemotherapy-induced nausea and vomiting (CINV) prevention. The paper synthesizes clinical and preclinical evidence demonstrating palonosetron's superior performance, particularly in the delayed phase of CINV, and discusses its mechanistic advantages and clinical implications.

• SAR131675: Precision VEGFR-3 Inhibition for Tumor and Lympha

  2026-06-18

  Explore SAR131675, a selective VEGFR-3 inhibitor, and its advanced application in dissecting tumor growth and lymphatic biology. This article delivers a uniquely integrative analysis, including mechanistic insights, experimental protocols, and translational implications for anti-lymphangiogenic research.

• Azilsartan Medoxomil Monopotassium: Translational Impact Unv

  2026-06-18

  This thought-leadership article explores the mechanistic depth and strategic value of Azilsartan medoxomil monopotassium (TAK 491) for translational hypertension and cardiovascular research. Integrating recent evidence and protocol guidance, it positions APExBIO’s compound as a pivotal enabler in the evolving landscape of blood pressure modulation and angiotensin II receptor signaling studies.

• Dimetridazole Restores Cefotaxime Efficacy via Membrane Disr

  2026-06-17

  The referenced study demonstrates that Dimetridazole, a 1,2-dimethyl-5-nitroimidazole, synergistically enhances cefotaxime activity against multidrug-resistant E. coli by disrupting membrane integrity and altering fatty acid biosynthesis. This mechanistic insight highlights drug repurposing as a promising strategy to tackle antimicrobial resistance and suggests practical avenues for combination therapy development.

• Synergistic Photodynamic Therapy and STING Activation in Bre

  2026-06-17

  This article reviews a recent study that combines targeted photodynamic therapy (PDT) using MHI148 with STING pathway activation via 2'3'-cGAMP to suppress breast cancer metastasis and recurrence. The research demonstrates how dual-modality nanomedicine overcomes key immunotherapy barriers, enhancing type I interferon induction and antitumor immunity.

• nor-NOHA Acetate: Precision Arginase Inhibition in Cancer Re

  2026-06-16

  nor-NOHA acetate is a potent, reversible arginase inhibitor central to studies of arginine metabolism and cancer biology. Its use enhances nitric oxide production, modulates cellular fate, and suppresses tumor cell proliferation and invasion. This article details the molecular rationale, evidence, limitations, and workflow protocols for nor-NOHA (acetate) as supplied by APExBIO.

• MLN2238 and the CRTC-CREB Axis: Rethinking Proteasome Inhibi

  2026-06-16

  This thought-leadership article explores the mechanistic and translational implications of MLN2238, a potent reversible proteasome β5 subunit inhibitor, in oncology and beyond. Drawing on recent discoveries in the CRTC-CREB axis, it offers strategic guidance for translational researchers studying proteotoxic stress, drug resistance, and innovative therapeutic avenues.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-06-15

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) offers clear, multi-color molecular weight standards for routine SDS-PAGE and Western blotting. It addresses the need for direct, visible size verification and transfer monitoring without EDTA interference. This marker should not be used in workflows requiring unstained or single-color standards, or where precise post-staining quantitation is required.

• AO/PI Staining Solution: Precision Fluorescent DNA Dye Assay

  2026-06-15

  AO/PI Staining Solution sets the benchmark for live/dead cell discrimination, utilizing dual fluorescent DNA dyes to deliver robust, interference-resistant viability data in both routine and advanced disease modeling workflows. Its optimized protocol eliminates the pitfalls of trypan blue, enabling highly accurate, reproducible results—even in complex samples such as PBMCs or nephropathy models.

• TRPV1+ Nerve Stimulation Suppresses Inflammation via Reflex

  2026-06-14

  This study demonstrates that selective stimulation of TRPV1-expressing peripheral somatosensory nerves, including through the capsaicin analog Nonivamide, rapidly suppresses systemic inflammation by activating specific somato-autonomic neural circuits. Findings clarify the anti-inflammatory mechanism of TRPV1 agonists, informing both fundamental neuroimmune research and translational strategies for inflammatory disease management.

• IR-1061: Next-Generation Near Infrared Dye for Deep Tissue I

  2026-06-13

  Explore IR-1061, a state-of-the-art near infrared fluorescent dye, and its transformative role in deep tissue in vivo imaging. This article offers a rigorous technical analysis, novel protocol guidance, and unique insights beyond existing reviews.

• Imatinib Hydrochloride: Strategic Advances in Translational

  2026-06-12

  Explore mechanistic insights and translational strategies for Imatinib hydrochloride (STI571 hydrochloride), emphasizing its evolving role in cancer research and dual-action kinase–phosphatase modulation. This article contextualizes the latest findings, competitive landscape, and workflow optimization for translational researchers.

• Hexa His Tag Peptide: Mechanistic Insights and Assay Optimiz

  2026-06-12

  Explore the molecular mechanisms and advanced assay strategies enabled by the Hexa His tag peptide. This article offers a unique, in-depth analysis of 6X His tag peptide applications, bridging protein purification and actin assembly insights for innovative experimental design.

• Lipid Nanoparticle Delivery of 2'3'-cGAMP Suppresses Pancrea

  2026-06-11

  This study demonstrates that encapsulating 2'3'-cGAMP in lipid nanoparticles significantly enhances its delivery to pancreatic tumor cells, leading to robust STING pathway activation and marked tumor inhibition in a syngeneic mouse model. The findings highlight an advanced strategy for overcoming delivery barriers and inflaming the tumor microenvironment in pancreatic cancer, with implications for future immunotherapy research.

16230 records 1/1082 page Next 12345 下5页 Last page